Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 14Burkitt Lymphoma 10Neoplasms 7Lymphoma, Follicular 6Hodgkin Disease 6Triple Negative Breast Neoplasms 5Sarcoma 5Ovarian Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma 5Endometrial Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, B-Cell 4Breast Neoplasms 4Wilms Tumor 3Sarcoma, Ewing 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, Mantle-Cell 3Liposarcoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Fallopian Tube Neoplasms 3Plasmablastic Lymphoma 2Neoplasm Metastasis 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphoma, B-Cell, Marginal Zone 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2

Interventions

liposomal doxorubicin 2pomalidomide 1Zidovudine 1Vincristine 1Valganciclovir 1Sirolimus 1Rituximab 1Prednisone 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multi-centric Castleman's Disease × Doxorubicin × 30 days × Clear all
NCT00092222 2026-06-01

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡